Frequency of ADIPOQ 276 and ADIPOQ 45 Polymorphisms in Obese and Eutrophic Adolescents with and without Asthma and their Relationship with Serum Adiponectin Levels

Main Article Content

Victor Gonzalez-Uribe, MD. MSc. Ricardo Martinez-Tenopala, MD Paola de Baro-Alvarez, MD Zaira Mojica-Gonzalez, MD

Abstract

Background: Asthma is a chronic allergic disease characterized by variable airflow limitation; Obesity is a chronic disease that has reached epidemic proportions globally. Both are diseases with a significant inflammatory component, and their relationship suggests being weight dependent. Adiponectin (ADIPOQ) is the main adipokine secreted by white adipose tissue, it is an insulin synthesizer and regulator of energy homeostasis, and its plasma levels are inversely correlated with obesity and asthma. The effect of genetic factors in both diseases has been investigated, and haplotypes of the ADIPOQ 45 T/G (rs2241766) and ADIPOQ 276 G/T (rs1501299) polymorphisms have been related.


Aims: To know de polymorphisms frequency of ADIPOQ 45 and ADIPO 276 in obese and eutrophic adolescents with and without asthma, likewise, link the adiponectin levels with the presence of such polymorphisms. 


Methods: An observational, analytical, and cross-sectional study in which 169 Mexican adolescents were recruited. Thirty mL of blood was taken from each individual; genomic DNA was extracted using the saline expulsion technique and quantified by spectrophotometry; two polymorphisms located in the promoter region were studied: ADIPOQ 45 and ADIPOQ 276; the determination of the different polymorphisms was carried out using TaqMan probes using real-time PCR (qPCR) using the commercial kit TaqMan One Step RT-PCR mastermix, the RNA extraction was carried out with Trizol Ls (Invitrogen), and the fluorescence was quantified employing the 7900HT ABI PRISM real-time computer SDS software.


Results: There were no statistically significant differences between ADIPOQ 276 and ADIPOQ 45 polymorphisms in asthmatic and obese patients. Compared to the control group, a negative correlation was observed between adiponectin plasmatic levels in obese and asthmatic individuals.


Conclusion: The ADIPOQ 276 and ADIPOQ 45 polymorphisms do not seem to be associated with asthma and obesity in the Mexican population. It is necessary to continue studying these polymorphisms and consider larger populations.

Keywords: adiponectin, asthma, obesity, polymorphisms, ADIPOQ 276, ADIPOQ 45

Article Details

How to Cite
GONZALEZ-URIBE, Victor et al. Frequency of ADIPOQ 276 and ADIPOQ 45 Polymorphisms in Obese and Eutrophic Adolescents with and without Asthma and their Relationship with Serum Adiponectin Levels. Medical Research Archives, [S.l.], v. 10, n. 9, sep. 2022. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3121>. Date accessed: 09 may 2024. doi: https://doi.org/10.18103/mra.v10i9.3121.
Section
Research Articles

References

1. Otelea MR, Arghir OC, Zugravu C, Rascu A. Adiponectin and asthma: Knowns, unknowns and controversies. International Journal of Molecular Sciences. 2021;22(16):8971. doi:10.3390/ijms22168971
2. Bantulà M, Roca-Ferrer J, Arismendi E, Picado C. Asthma and obesity: Two diseases on the rise and bridged by inflammation. Journal of Clinical Medicine. 2021;10(2):169. doi:10.3390/jcm10020169
3. Lin X, Li H. Obesity: Epidemiology, pathophysiology, and therapeutics. Frontiers in Endocrinology. 2021;12. doi:10.3389/fendo.2021.706978
4. Palomer X, Pérez A, Blanco-Vaca F. Adiponectin: a new link between obesity, insulin resistance and cardiovascular disease. Medicina Clínica. 2005;124(10):388-395. doi:10.1157/13072576
5. Tilija Pun N, Subedi A, Kim MJ, Park P-H. Globular adiponectin causes tolerance to LPS-induced TNF-α expression via autophagy induction in raw 264.7 macrophages: Involvement of SIRT1/FoxO3A Axis. PLOS ONE. 2015;10(5). doi:10.1371/journal.pone.0124636
6. Salvator H, Grassin-Delyle S, Naline E, et al. Contrasting effects of adipokines on the cytokine production by primary human bronchial epithelial cells: Inhibitory effects of adiponectin. Frontiers in Pharmacology. 2020;11. doi:10.3389/fphar.2020.00056
7. Zhang M-Y, Dini AA, Yang X-K, et al. Association between serum/plasma adiponectin levels and immune-mediated diseases: A meta-analysis. Archives of Dermatological Research. 2017;309(8):625-635. doi:10.1007/s00403-017-1755-y
8. Ma C, Wang Y, Xue M. Correlations of severity of asthma in children with body mass index, adiponectin and leptin. Journal of Clinical Laboratory Analysis. 2019;33(6). doi:10.1002/jcla.22915
9. Ziora-Jakutowicz KN, Zimowski J, Ziora K, et al. Evaluation of the frequency of ADIPOQ c.45 T>G and ADIPOQ c.276 g>T polymorphisms in adiponectin coding gene in girls with anorexia nervosa. Endokrynologia Polska. 2021;72(5):520-528. doi:10.5603/ep.a2021.0064
10. Wu J, Liu Z, Meng K, Zhang L. Association of adiponectin gene (ADIPOQ) RS2241766 polymorphism with obesity in adults: A meta-analysis. PLoS ONE. 2014;9(4). doi:10.1371/journal.pone.0095270
11. Ramya K, Ayyappa KA, Ghosh S, Mohan V, Radha V. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in South Indian population. Gene. 2013;532(2):253-262. doi:10.1016/j.gene.2013.09.012
12. Ding Y, Yang H, He H, He P, Yan S, Jin T. Plasma adiponectin concentrations and adiponectin gene polymorphisms are associated with bronchial asthma in the Chinese Li population. Iranian Journal of Allergy, Asthma and Immunology. 2015;14(3):292-297.
13. Méndez-Hernández A, Gallegos-Arreola MP, Moreno-Macías H, Espinosa Fematt J, Pérez-Morales R. LEP RS7799039, LEPR rs1137101, and ADIPOQ RS2241766 and 1501299 polymorphisms are associated with obesity and chemotherapy response in Mexican women with breast cancer. Clinical Breast Cancer. 2017;17(6):453-462. doi:10.1016/j.clbc.2017.03.010
14. Juárez-Cedillo T, Zuñiga J, Acuña-Alonzo V, et al. Genetic admixture and diversity estimations in the Mexican mestizo population from Mexico City using 15 STR polymorphic markers. Forensic Science International: Genetics. 2008;2(3). doi:10.1016/j.fsigen.2007.08.017
15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research. 1988;16(3):1215-1215. doi:10.1093/nar/16.3.1215
16. Almeida MC, Silva AC, Barral A, Barral Netto M. A simple method for human peripheral blood monocyte isolation. Memórias do Instituto Oswaldo Cruz. 2000;95(2):221-223. doi:10.1590/s0074-02762000000200014
17. de Lima Sanches, Priscila et al. “Improvement in HOMA-IR is an independent predictor of reduced carotid intima-media thickness in obese adolescents participating in an interdisciplinary weight-loss program.” Hypertension research: official journal of the Japanese Society of Hypertension vol. 34,2 (2011): 232-8. doi:10.1038/hr.2010.225
18. Tock, Lian et al. “Nonalcoholic fatty liver disease decreases in obese adolescents after multidisciplinary therapy.” European journal of gastroenterology & hepatology vol. 18,12 (2006): 1241-5. doi:10.1097/01.meg.0000243872.86949.95
19. Caranti, Danielle Arisa et al. “Short- and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents.” Metabolism: clinical and experimental vol. 56,9 (2007): 1293-300. doi:10.1016/j.metabol.2007.05.004
20. Sood, Akshay. “Altered resting and exercise respiratory physiology in obesity.” Clinics in chest medicine vol. 30,3 (2009): 445-54, vii. doi:10.1016/j.ccm.2009.05.003
21. Lugogo, Njira L et al. “Does obesity produce a distinct asthma phenotype?” Journal of applied physiology (Bethesda, Md. : 1985) vol. 108,3 (2010): 729-34. doi:10.1152/japplphysiol.00845.2009
22. Parameswaran, Krishnan et al. “Altered respiratory physiology in obesity.” Canadian respiratory journal vol. 13,4 (2006): 203-10. doi:10.1155/2006/834786
23. Sood, Akshay. “Obesity, adipokines, and lung disease.” Journal of applied physiology (Bethesda, Md.: 1985) vol. 108,3 (2010): 744-53. doi:10.1152/japplphysiol.00838.2009
24. Jartti, T et al. “Obesity, adipokines and asthma.” Allergy vol. 64,5 (2009): 770-7. doi:10.1111/j.1398-9995.2008.01872.x
25. Payab M, Amoli MM, Qorbani M, Hasani-Ranjbar S. Adiponectin gene variants and abdominal obesity in an Iranian population. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity. 2016;22(1):85-90. doi:10.1007/s40519-016-0252-1
26. Lu J-fu, Zhou Y, Huang G-hua, Jiang H-xing, Hu B-li, Qin S-yu. Association of ADIPOQ polymorphisms with Obesity Risk: A meta-analysis. Human Immunology. 2014;75(10):1062-1068. doi:10.1016/j.humimm.2014.09.004
27. Harris, Holly R et al. “Plasma leptin levels and risk of breast cancer in premenopausal women.” Cancer prevention research (Philadelphia, Pa.) vol. 4,9 (2011): 1449-56. doi:10.1158/1940-6207.CAPR-11-0125
28. Grøntved, Anders et al. “Association between plasma leptin and blood pressure in two population-based samples of children and adolescents.” Journal of hypertension vol. 29,6 (2011): 1093-100. doi:10.1097/HJH.0b013e328346d787
29. Schmidt, M I et al. “Leptin and incident type 2 diabetes: risk or protection?.” Diabetologia vol. 49,9 (2006): 2086-96. doi:10.1007/s00125-006-0351-z
30. Fenger, R V et al. “Exploring the obesity-asthma link: do all types of adiposity increase the risk of asthma?.” Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology vol. 42,8 (2012): 1237-45. doi:10.1111/j.1365-2222.2012.03972.x